If a company is planning to market a medical device that is substantially equivalent to a device marketed before 1976. t can use one of the following regulatory paths:
A. IDE B. PMA C. 510(k) D. Special Assessment Protocol
Answer: C
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.